The preneoplastic phenotype in murine mammary tumorigenesis

Journal of Mammary Gland Biology and Neoplasia

Volumn 5, Issue 4, 2000, Pages 393-407

  Medina, D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Biological phenotype; Ductal hyperplasia; Hyperplastic alveolar nodule; Molecular phenotype; Preneoplasia

Indexed keywords

CARCINOGEN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DNA; PROTEIN P53;

ANEUPLOIDY; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; CANCER GROWTH; CELL CYCLE; CELL HETEROGENEITY; CELL IMMORTALIZATION; DISEASE MODEL; ENZYME ACTIVITY; EPITHELIUM HYPERPLASIA; GENE EXPRESSION; GENE MUTATION; HORMONE DEPENDENCE; IRRADIATION; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; ONCOGENE; ONCOVIRINAE; PHENOTYPE; PRECANCER; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; HUMANS; HYPERPLASIA; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PHENOTYPE; PRECANCEROUS CONDITIONS;

EID: 0034458579     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009529928422     Document Type: Review

References (102)

1. The mammary gland: A unique organ for the study of development and tumorigenesis
2. The sequential analysis of cancer development
3. Multistage carcinogenesis: Population-based model for colon cancer
4. Preneoplasia in mammary tumorigenesis
5. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice
6. Biology of breast preneoplasia
7. Preneoplastic lesions in mouse mammary tumorigenesis
8. New methods for detection of mouse mammary tumor virus. I. Influence of foster nursing on incidence of hyperplastic mammary nodules in BALB/cCrgl mice
9. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene
10. Effects of various oncogenic agents on the tumor-producing capabilities of the D series of BALB/c mammary nodule outgrowth lines
11. Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-α-ergocryptine
12. Stage specificity of selenium-mediated inhibition of mouse mammary tumorigenesis
13. Biochemical characteristics of mouse mammary tissues, preneoplastic lesions and tumors
14. Protoneoplasia: The molecular biology of murine mammary hyperplasia
15. Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype
16. An entire mammary gland may comprise the prrogeny from a single cell
17. Mammary tumorigenesis in chemical carcinogene-treated mice. IV. Induction of mammary ductal hyperplasia
18. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/C mice
19. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice
20. Control of mammary gland development
21. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice
22. Serial transplantation of chemical carcinogen-induced mouse mammary ductal dysplasias
23. Delayed involution of the mammary epithelium in BALB/c-p53 null mice
24. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development
25. Biological features of premalignant disease in the human breast
26. A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland
27. 40 T-antigen transgenic mouse model of mammary cancer: Ductal epithelial cell targeting with multistage progression to carcinoma
28. Unlimited division potential of precancerous mouse mammary cells after spontaneous or carcinogen-induced transformation
29. Regulation of growth and spacing of gland elements in the mammary fat pad of the C3H mouse
30. Aging of cells during serial propagation in vivo
31. Expression of differentiation-specific proteins in preneoplastic mammary tissues in BALB/c mice
32. Gene control of neoplasia. I. Genotypic mosaicism in normal and preneoplastic mammary glands of allophenic mice
33. Detection of inapparent nodule-transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice
34. Enhancement of the tumorigenicity of preneoplastic mammary nodule lines by enzymatic dissociation
35. Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo
36. Morphological and functional properties of TM preneoplastic mammary outgrowths
37. Development of mammary preneoplasias in vivo from mouse mammary epithelial cells in vitro
38. Interactions of apoptosis, proliferation and host age in the regression of the mouse mammary preneoplasia TM3 carrying an unusual mutation in p53
39. Expression of MMTV-LTRORF promotes tumorigenic potential of hyperplastic mouse mammary epithelial cells
40. Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis
41. Radiation-induced apoptosis in normal and preneoplastic mammary glands in vivo: Significance of gland differentiation and p53 status
42. Mode of proviral activation of a putative mammary oncogene int-1 on mouse chromosome 15
43. Tumorigenesis by mouse mammary tumor virus: Evidence for a common region for a common region for provirus integration in mammary tumors
44. Mammary tumorigenesis in feral mice: Identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors
45. Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia
46. A new site of integration for mouse mammary tumor virus proviral DNA common to BALB/cfC3H mammary and kidney adenocarcinomas
47. Wnt-3, a gene activated by proviral insertion in mouse tumors, is homologous to int-1/Wnt-1 and is normally expressed mouse embryos and adult brain
48. The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertin in some virally induced mammary tumors
49. Characterization of int-5, a locus associated with early events in mammary carcinogenesis
50. Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development
51. Multiple RNAs expressed from the int-2 gene in mouse embryonal carcinoma cell lines encode a protein with homology to fibroblast growth factors
52. The nature and expression of int-5, a novel MMTV integration locus gene in carcinogen-induced mammary tumors
53. Mouse mammary tumor gene INT-3: A member of the Notch gene family transforms mammary epithelial cells
54. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
55. Transgene expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice
56. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland
57. A common mouse mammary tumor virus integration site in chemically induced precancerous mammary hyperplasia
58. The overexpression of int-5/aromatose, a novel MMTV integration locus gene, is responsible for D2 mammary tumor cell proliferation
59. A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene
60. Aromatase overexpression and breast hyperplasia, an in vivo model - Continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands
61. Multistep model of mouse mammary tumor development
62. The effect of parity, tumor latency and transplantation on the activation of int loci in MMTV-induced, transplanted C3H mammary pre-neoplasias and their tumors
63. Mammary tumorigenesis in C3Hf/Ki mice: Examination of germinal mouse mammary tumor viruses and the int-1 and int-2 putative proto-oncogenes
64. Activation of endogenous MMTV provirus in murine mammary cancer induced by chemical carcinogens
65. Spontaneous progression of hyperplastic outgrowths of the D1 lineage to mammary tumors: Expression of mouse mammary tumor virus and cellular proto-oncogenes
66. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells
67. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats
68. Specific activation of the cellular Harvey-ras oncogene in dimethylbenz-antracene-induced mouse mammary tumors
69. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues
70. Restriction endonuclease studies of hyperplastic outgrowth lines form BALB/cfC3HY mouse hyperplastic mammary nodules
71. Hormones, growth factors and gene expression in preneoplasias of the mouse mammary gland
72. Expression of a translationally regulated, dominant-negative C/EBPB isoform and upregulation of the eukaryotic translation initiation factor (eIF) 2α are correlated with neoplastic transformation of mammary epithelial cells
73. Protein kinase C isozymes and substrates in mammary carcinogenesis
74. Cell cyclins and cyclin dependent kinase activities in mouse mammary tumor development
75. Immortalized mouse mammary cells in vivo do not exhibit increased telomerase activity
76. p96, a MAPK-related protein, is consistently downregulated during mouse mammary tumorigenesis
77. Biological features of human premalignant breast disease
78. p53 mutations selected in vivo when mouse mammary epithelial cells from hyperplastic outgrowths are not necessary for establishment of mammary cells in vitro
79. A transgenic mouse model for mammary carcinogenesis
80. Immortal non-tumorigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase
81. Cyclins and breast cancer
82. The biology of mammary transgenes: Five rules
83. Genetically engineered mouse models of mammary intraepithelial neoplasia
84. Role of endocrine, autocrine and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice
85. The int-2 gene product acts as an epithelial growth factor in transgenic mice
86. Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants
87. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
88. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice
89. Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast
90. Synergistic interaction of transforming growth factor α and c-myc in mouse mammary and salivary gland tumorigenesis
91. Deficiency of p53 accelerates mammary tumorigenesis in wnt-1 transgenic mice and promotes chromosomal instability
92. Accelaration of mammary neoplasia in transforming growth factor α transgenic mice by 7,12-dimethylbenzanthracene
93. Preferential overexpression of a 172 Arg-Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development
94. Inhibition of mammary ductal development but not alveolar outgrowth during pregnancy in transgenic mice expression active TGFB1
95. Targeting expression of a TGFB1 transgene to the pregnant mammary gland inhibits alveolar development and lactation
96. Ectopic TGFB1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population
97. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands
98. Constitutive expression of a truncated int-3 gene in mouse mammary epithelium impairs differentiation and functional development
99. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis
100. Evidence of separate pathways for viral and chemical carcinogenesis in C3H/StWi mouse mammary glands
101. In search of mammary gland stem cells
102. Mechanism-based cancer prevention approaches: Targets, examples, and the use of transgenic mice